UA79674C2 - Triazol compounds suitable for use in therapeutics - Google Patents

Triazol compounds suitable for use in therapeutics Download PDF

Info

Publication number
UA79674C2
UA79674C2 UAA200508142A UA2005008142A UA79674C2 UA 79674 C2 UA79674 C2 UA 79674C2 UA A200508142 A UAA200508142 A UA A200508142A UA 2005008142 A UA2005008142 A UA 2005008142A UA 79674 C2 UA79674 C2 UA 79674C2
Authority
UA
Ukraine
Prior art keywords
compound
chloro
tetrahydro
formula
dichloromethane
Prior art date
Application number
UAA200508142A
Other languages
English (en)
Ukrainian (uk)
Inventor
Justin Stephen Bryans
Patrick Stephen Johnson
Thomas Ryckmans
Alan Stobie
Rachel Jane Russell
Christopher Peter Wayman
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2004/000432 external-priority patent/WO2004074291A1/en
Application filed by Pfizer filed Critical Pfizer
Publication of UA79674C2 publication Critical patent/UA79674C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
UAA200508142A 2003-07-23 2004-09-02 Triazol compounds suitable for use in therapeutics UA79674C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0317227.7A GB0317227D0 (en) 2003-07-23 2003-07-23 Treatment of male sexual dysfunction
PCT/IB2004/000432 WO2004074291A1 (en) 2003-02-19 2004-02-09 Triazole compounds useful in therapy

Publications (1)

Publication Number Publication Date
UA79674C2 true UA79674C2 (en) 2007-07-10

Family

ID=27772516

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200508142A UA79674C2 (en) 2003-07-23 2004-09-02 Triazol compounds suitable for use in therapeutics

Country Status (12)

Country Link
EP (1) EP1656183B1 (cg-RX-API-DMAC7.html)
JP (1) JP2006528171A (cg-RX-API-DMAC7.html)
AT (1) ATE380048T1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0412255A (cg-RX-API-DMAC7.html)
CA (1) CA2533177A1 (cg-RX-API-DMAC7.html)
CL (1) CL2004001702A1 (cg-RX-API-DMAC7.html)
GB (1) GB0317227D0 (cg-RX-API-DMAC7.html)
MX (1) MXPA05014200A (cg-RX-API-DMAC7.html)
TW (1) TW200510424A (cg-RX-API-DMAC7.html)
UA (1) UA79674C2 (cg-RX-API-DMAC7.html)
WO (1) WO2005006899A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200505957B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1663978T3 (pl) 2003-07-23 2008-04-30 Bayer Healthcare Llc Fluoropodstawiony omega-karboksyarylodifenylomocznik do leczenia i profilaktyki chorób i stanów
GB0504556D0 (en) * 2005-03-04 2005-04-13 Pfizer Ltd Novel pharmaceuticals
JP2008533192A (ja) * 2005-03-21 2008-08-21 ファイザー・リミテッド オキシトシンアンタゴニストとしての置換されたトリアゾール誘導体
US20220152032A1 (en) * 2020-11-13 2022-05-19 Pharma America Holding Inc. Sexual therapy formulation and method of treatment
CN117414361B (zh) * 2023-09-28 2026-08-07 华中农业大学 一种化合物在预防和治疗革兰氏阴性菌病方面的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2000223275A1 (en) * 2000-02-08 2001-08-20 Yamanouchi Pharmaceutical Co..Ltd. Novel triazole derivatives
GB0224919D0 (en) * 2002-10-25 2002-12-04 Pfizer Ltd Triazole compounds useful in therapy

Also Published As

Publication number Publication date
CL2004001702A1 (es) 2005-05-13
CA2533177A1 (en) 2005-01-27
EP1656183A1 (en) 2006-05-17
ATE380048T1 (de) 2007-12-15
WO2005006899A1 (en) 2005-01-27
BRPI0412255A (pt) 2006-09-19
MXPA05014200A (es) 2006-07-03
TW200510424A (en) 2005-03-16
ZA200505957B (en) 2006-11-29
GB0317227D0 (en) 2003-08-27
JP2006528171A (ja) 2006-12-14
EP1656183B1 (en) 2007-12-05

Similar Documents

Publication Publication Date Title
EP3215509B1 (en) Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders
AU2013334236B2 (en) Heteroaryl inhibitors of PDE4
CN106029076B (zh) 作为bet溴域抑制剂的苯并哌嗪组合物
CN105939997B (zh) 作为dlk抑制剂的吡唑衍生物及其用途
TW201910328A (zh) 雜環化合物
UA122433C2 (uk) Заміщена піперидинова сполука та її застосування
WO2020042995A1 (zh) 一种高活性sting蛋白激动剂化合物
CN108289893B (zh) 人类血浆激肽释放酶抑制剂
TW201031407A (en) Novel compounds
EP4406616A2 (en) Substituted pyrazolo(1,5-a)pyrimidines and their use in the treatment of medical disorders
HUP0104280A2 (hu) Dopamin D3 receptorok modulátoraiként felhasználható tetrahidrobenzazepin-származékok, eljárás az előállításukra, a vegyületeket tartalmazó gyógyszerkészítmények
CN112292374B (zh) 一种新型磷酸肌醇3-激酶抑制剂及其制备方法和用途
TW202128642A (zh) 用於疾病治療之雙白胺酸拉鍊(dlk)激酶的雙環[1.1.1]戊烷抑制劑
JPH09512528A (ja) バソプレッシン拮抗物質としてのベンズアミド誘導体
CN115667226A (zh) 作为egfr抑制剂的三环化合物
WO2020038387A1 (zh) 高活性sting蛋白激动剂
JP2022097655A (ja) 非ペプチドオキシトシン受容体アゴニスト
TWI826492B (zh) 經取代四氫環戊[c]吡咯、經取代二氫吡咯,其類似物及使用其之方法
JPWO2006033318A1 (ja) 環状アミン誘導体又はその塩
CN108884093A (zh) 6,7,8,9-四氢-5H-吡啶并[2,3-d]氮杂*多巴胺D3配体
JPH08508039A (ja) 選択的コレシストキニン−b受容体拮抗薬としてのテトラヒドロ−1h−ベンゾアゼピノンおよびヘキサヒドロアゼピノン
EP1784408A1 (en) Triazolobenzodiazepines and their use as vasopressin antagonists
CN115066423B (zh) Pd-l1拮抗剂化合物
EA009460B1 (ru) Триазольные соединения, полезные в терапии
TW202208374A (zh) 經取代三環醯胺類、其類似物及使用其之方法